Respiratory failure due to pulmonary lymphangitis carcinomatosis.

Abstract

A man with primary lung cancer developed respiratory failure due to lymphangitis carcinomatosis that was diagnosed by transbronchial lung biopsy specimen. After combination chemotherapy with high-dose etoposide and cisplatin (CDDP), he was able to cease oxygen therapy and showed improvement of his lymphangitis carcinomatosis. He received a total dose of 13,400 mg/m2 of etoposide. This case suggested that respiratory failure due to lymphangitis carcinomatosis can be a treatable condition.

• Authors: J Fujita, Y Yamagishi, A Kubo, K Takigawa, Y Yamaji, J Takahara
• Journal: Chest (Chest) Vol. 103 Issue 3 Pg. 967-8 (Mar 1993) ISSN: 0012-3692 [Print] United States
• PMID: 8449110 (Publication Type: Case Reports, Comparative Study, Journal Article)

Chemical References

• Etoposide
• Cisplatin
• Fluorouracil

Topics

• Adenocarcinoma (complications, drug therapy)
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Cisplatin (administration & dosage)
• Etoposide (administration & dosage)
• Fluorouracil (administration & dosage)
• Humans
• Lung Neoplasms (complications, drug therapy)
• Lymphangitis (complications, drug therapy)
• Lymphatic Metastasis
• Male
• Middle Aged
• Respiratory Insufficiency (drug therapy, etiology)